Li L - Search Results

1

Identification of a Functional ceRNA Network to Explore Potential Biomarkers for Hepatocellular Carcinoma.

Jiang Z, Zhang Y, Liu X, Liang J, Qiu G, Zhu X, Chen J, Li L. Jiang Z, et al. Among authors: li l. Onco Targets Ther. 2020 Dec 1;13:12341-12355. doi: 10.2147/OTT.S278912. eCollection 2020. Onco Targets Ther. 2020. PMID: 33293827 Free PMC article.

2

Epidermal growth factor gene polymorphism and risk of hepatocellular carcinoma: a meta-analysis.

Zhong JH, You XM, Gong WF, Ma L, Zhang Y, Mo QG, Wu LC, Xiao J, Li LQ. Zhong JH, et al. Among authors: li lq. PLoS One. 2012;7(3):e32159. doi: 10.1371/journal.pone.0032159. Epub 2012 Mar 5. PLoS One. 2012. PMID: 22403631 Free PMC article.

3

Combination Of ALBI And APRI To Predict Post-Hepatectomy Liver Failure After Liver Resection For HBV-Related HCC Patients.

Mai RY, Wang YY, Bai T, Chen J, Xiang BD, Wu GB, Wu FX, Li LQ, Ye JZ. Mai RY, et al. Cancer Manag Res. 2019 Oct 2;11:8799-8806. doi: 10.2147/CMAR.S213432. eCollection 2019. Cancer Manag Res. 2019. PMID: 31632139 Free PMC article.

4

Multifunctional Nanoparticles-Mediated PTT/PDT Synergistic Immune Activation and Antitumor Activity Combined with Anti-PD-L1 Immunotherapy for Breast Cancer Treatment.

Kong C, Xu B, Qiu G, Wei M, Zhang M, Bao S, Tang J, Li L, Liu J. Kong C, et al. Among authors: li l. Int J Nanomedicine. 2022 Nov 17;17:5391-5411. doi: 10.2147/IJN.S373282. eCollection 2022. Int J Nanomedicine. 2022. PMID: 36419717 Free PMC article.

5

Conversion surgery for initially unresectable hepatocellular carcinoma using lenvatinib combined with TACE plus PD-1 inhibitor: A real-world observational study.

Li X, Wang X, Bai T, Chen J, Lu S, Wei T, Tang Z, Zhao G, Lu H, Li L, Wu F. Li X, et al. Among authors: li l. Dig Liver Dis. 2024 Jun;56(6):1078-1086. doi: 10.1016/j.dld.2023.11.027. Epub 2023 Dec 19. Dig Liver Dis. 2024. PMID: 38114383

6

Ubiquitination of P53 Regulated by Ubiquitin-Specific Protease 14 Delays the Invasion of Hepatitis B Virus and the Development of Hepatitis.

Bai T, Mai RY, Tang ZH, Wang XB, Chen J, Ye JZ, Wei M, Zhang B, Li K, Gu ZM, Wu FX, Li LQ. Bai T, et al. Viral Immunol. 2024 Nov;37(9):432-439. doi: 10.1089/vim.2024.0066. Viral Immunol. 2024. PMID: 39601371

7

Artificial Neural Network Model for Liver Cirrhosis Diagnosis in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma.

Mai RY, Zeng J, Mo YS, Liang R, Lin Y, Wu SS, Piao XM, Gao X, Wu GB, Li LQ, Ye JZ. Mai RY, et al. Ther Clin Risk Manag. 2020 Jul 17;16:639-649. doi: 10.2147/TCRM.S257218. eCollection 2020. Ther Clin Risk Manag. 2020. PMID: 32764948 Free PMC article.

8

Postoperative adjuvant transarterial chemoembolization for participants with hepatocellular carcinoma: A meta-analysis.

Zhong JH, Li LQ. Zhong JH, et al. Hepatol Res. 2010 Oct;40(10):943-53. doi: 10.1111/j.1872-034X.2010.00710.x. Hepatol Res. 2010. PMID: 20887328

9

Curcumin Attenuates Oxaliplatin-Induced Liver Injury and Oxidative Stress by Activating the Nrf2 Pathway.

Lu Y, Wu S, Xiang B, Li L, Lin Y. Lu Y, et al. Among authors: li l. Drug Des Devel Ther. 2020 Jan 9;14:73-85. doi: 10.2147/DDDT.S224318. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32021093 Free PMC article.

10

C-Reactive Protein-Albumin Ratio (CAR): A More Promising Inflammation-Based Prognostic Marker for Patients Undergoing Curative Hepatectomy for Hepatocellular Carcinoma.

Mai RY, Lu TL, Lu RJ, Zeng C, Lian F, Li LQ, Wu GB, Ye JZ. Mai RY, et al. J Inflamm Res. 2024 Feb 12;17:919-931. doi: 10.2147/JIR.S441623. eCollection 2024. J Inflamm Res. 2024. PMID: 38370468 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99,858 results

Search Page

Filters